KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Equity Average (2018 - 2025)

Historic Equity Average for Novartis Ag (NVS) over the last 7 years, with Q1 2025 value amounting to $22.4 billion.

  • Novartis Ag's Equity Average changed N/A to $22.4 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $22.4 billion, marking a year-over-year change of. This contributed to the annual value of $45.3 billion for FY2025, which is 22.12% down from last year.
  • As of Q1 2025, Novartis Ag's Equity Average stood at $22.4 billion.
  • Novartis Ag's 5-year Equity Average high stood at $34.4 billion for Q1 2022, and its period low was $842.0 million during Q2 2023.
  • Moreover, its 4-year median value for Equity Average was $25.7 billion (2021), whereas its average is $19.6 billion.
  • Per our database at Business Quant, Novartis Ag's Equity Average surged by 1834.51% in 2022 and then crashed by 1230.74% in 2023.
  • Over the past 4 years, Novartis Ag's Equity Average (Quarter) stood at $913.0 million in 2021, then surged by 3663.58% to $34.4 billion in 2022, then tumbled by 97.55% to $842.0 million in 2023, then surged by 2565.8% to $22.4 billion in 2025.
  • Its Equity Average stands at $22.4 billion for Q1 2025, versus $842.0 million for Q2 2023 and $30.1 billion for Q1 2023.